Novel Compounds as SMARCA2 Inhibitors for Treating Non-Small Cell Lung Cancer
0 citations
Abstract
Abstract Provided herein are novel compounds as SMARCA2 inhibitors, pharmaceutical compositions, use of such compounds in treating non-small cell lung cancer (NSCLE), and processes for preparing such compounds.
// Source
Authors: Ram W. Sabnis